Skip to main content

Table 2 Characteristics of patients with clinical cure and clinical failure

From: Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection

 

Clinical cure (n = 229)

Clinical failure (n = 20)

P value

Age (years)

60 (45–73)

56 (46–71)

0.412

Male sex

94 (41)

7 (35)

0.597

Urologic history

 Indwelling urinary catheter

7 (3)

0

0.428

 Urinary tract disordera

71 (31)

4 (20)

0.304

 Recurrent UTIb

50 (22)

7 (35)

0.191

Comorbidity

 Diabetes mellitus

32 (14)

1 (5)

0.256

 Malignancy

16 (7)

1 (5)

0.735

 Heart failure

21 (9)

0

0.157

 Cerebrovascular disease

12 (5)

1 (5)

0.963

 Chronic renal insufficiency

8 (3)

1 (5)

0.729

 COPD

27 (11)

2 (10)

0.899

 Immunocompromised

14 (6)

1 (5)

0.841

Presentation

 At emergency department

160 (70)

15 (75)

0.630

 Antibiotic pre-treatment

71 (31)

2 (10)

0.048

 Fever duration, hours

36 (18–72)

48 (24–120)

0.279

 Dysuria

175/224 (78)

13/19 (68)

0.332

 Flank pain

142/225 (63)

17 (85)

0.049

 Suprapubic pain

116/222 (52)

11 (55)

0.814

 Perineal pain

11/222 (5)

0/19 (0)

0.321

 Systolic BP, mmHg

130 (116–146)

130 (115–150)

0.753

 Diastolic BP, mmHg

74 (63–85)

72 (68–83)

0.585

 Heart rate, beats/minute

93 (80–107)

96 (78–110)

0.695

Cultures

 Positive urine culture

158 (69)

13 (65)

0.712

 Escherichia coli

133/158 (84)

10/13 (77)

0.497

 Positive blood culture

42/220 (19)

3 (15)

0.654

 Positive urine and/or blood culture

169 (74)

14 (70)

0.712

Treatment

 Short antimicrobial treatment (7 days)

82 (36)

10 (50)

0.207

 Days of AB, mean (SD)

11 (3.3)

11 (3.5)

0.252

 Ciprofloxacin

208 (91)

18 (90)

0.902

 Amoxicillin (± clavulanic acid)

11 (5)

2 (10)

0.316

 TMP/SMX

5 (2)

0

0.504

 Otherc

5 (2)

0

0.504

 Initial intravenous dose(s) of AB

135 (59)

12 (60)

0.927

 Randomized

155 (68)

10 (50)

0.109

 Outpatient treatment

89 (39)

7 (35)

0.733

  1. Data presented as number (%) or median (IQR)
  2. BP blood pressure, AB antibiotics, TMP/SMX trimethoprim-sulfamethoxazole
  3. aany functional or anatomical abnormality of urinary tract except urinary catheter
  4. b≥3 UTIs in past 12 months or ≥ 2 UTIs in past 6 months
  5. ccefuroxime iv n = 2, meropenem iv n = 1, moxifloxacin n = 1, flucloxacillin n = 1